| |
| |
|
| Insider
Information: |
Crane Alan L |
| Relationship: |
Director, 10% Owner |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
721,021 |
|
|
Indirect Shares
|
4,771,739 |
|
|
| Direct
Value |
$32,251,736 |
|
|
|
Indirect Value
|
$2,054,711 |
|
|
| Total
Shares |
5,492,760 |
|
|
| Total
Value |
$34,306,447 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Momenta Pharmaceuticals Inc |
MNTA |
Former Director |
2010-04-14 |
613,820 |
2004-06-25 |
0 |
Premium* |
|
|
Dare Bioscience Inc |
DARE |
Director, 10% Owner |
2014-04-10 |
77,201 |
2014-04-15 |
4,771,739 |
Premium* |
|
|
T2 Biosystems, Inc. |
TTOO |
Director |
2014-08-12 |
30,000 |
2014-08-12 |
0 |
Premium* |
|
|
Pandion Therapeutics, Inc. |
PAND |
Director, 10% Owner |
2021-04-01 |
0 |
2021-04-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| MNTA |
Momenta Pharmaceuticals I... |
President, C.E.O. |
• • – |
2006-08-09 |
4 |
S |
$15.36 |
$6,144 |
D/D |
(400) |
1,165,749 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
President, C.E.O. |
• • – |
2006-08-30 |
4 |
S |
$16.25 |
$819,661 |
D/D |
(50,000) |
1,161,360 |
|
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
President, C.E.O. |
• • – |
2006-08-31 |
4 |
S |
$16.40 |
$542,490 |
D/D |
(33,000) |
1,161,360 |
|
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
C.E.O. |
• • – |
2006-09-05 |
4 |
S |
$15.86 |
$343,357 |
D/D |
(21,600) |
1,161,360 |
|
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
C.E.O. |
• • – |
2006-09-07 |
4 |
S |
$15.35 |
$190,371 |
D/D |
(12,402) |
1,161,360 |
|
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Director |
– • – |
2006-12-18 |
4 |
S |
$16.06 |
$4,818 |
D/D |
(300) |
689,589 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Former Director |
– – – |
2010-04-14 |
4/A |
OE |
$0.99 |
$146,960 |
D/D |
35,200 |
613,820 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Former Director |
– – – |
2010-04-14 |
4 |
OE |
$0.99 |
$146,960 |
D/D |
35,200 |
613,802 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
President & CEOOfficer |
• • – |
2004-06-21 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,010,859 |
|
- |
|
| DARE |
Dare Bioscience Inc |
Director |
– • • |
2014-04-10 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
77,201 |
|
- |
|
| PAND |
Pandion Therapeutics, Inc... |
Director |
– • • |
2020-07-16 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
49,025 |
|
- |
|
| PAND |
Pandion Therapeutics, Inc... |
Director |
– • • |
2020-07-16 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
336,314 |
|
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
President, CEO |
• • – |
2006-02-17 |
4 |
GD |
$0.00 |
$0 |
D/D |
25,000 |
1,011,360 |
|
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Director |
– • – |
2008-08-15 |
4 |
GD |
$0.00 |
$0 |
D/D |
6,600 |
579,742 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Director |
– • – |
2008-08-25 |
4 |
GD |
$0.00 |
$0 |
D/D |
690 |
579,052 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Director |
– • – |
2008-08-26 |
4 |
GD |
$0.00 |
$0 |
D/D |
450 |
578,602 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Director |
– • – |
2006-09-17 |
4 |
D |
$0.00 |
$0 |
D/D |
(200,000) |
861,342 |
0 |
- |
|
| PAND |
Pandion Therapeutics, Inc... |
Director |
– • • |
2021-04-01 |
4 |
D |
$60.00 |
$212,264,160 |
I/I |
(3,537,736) |
0 |
0 |
- |
|
| PAND |
Pandion Therapeutics, Inc... |
Director |
– • • |
2021-04-01 |
4 |
D |
$60.00 |
$5,049,480 |
D/D |
(84,158) |
0 |
0 |
- |
|
| DARE |
Dare Bioscience Inc |
Director |
– • • |
2014-04-15 |
4 |
B |
$7.00 |
$10,294,074 |
I/I |
1,470,582 |
4,771,739 |
2.25 |
- |
|
| TTOO |
T2 Biosystems, Inc. |
Director |
– • – |
2014-08-12 |
4 |
B |
$11.00 |
$330,000 |
D/D |
30,000 |
30,000 |
2.39 |
- |
|
| PAND |
Pandion Therapeutics, Inc... |
Director |
– • • |
2020-07-21 |
4 |
B |
$18.00 |
$649,998 |
I/I |
36,111 |
110,621 |
2.25 |
- |
|
| PAND |
Pandion Therapeutics, Inc... |
Director |
– • • |
2020-07-21 |
4 |
B |
$18.00 |
$252,000 |
D/D |
14,000 |
84,158 |
3.92 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
President, C.E.O. |
• • – |
2006-08-08 |
4 |
AS |
$15.00 |
$316,970 |
D/D |
(20,300) |
1,191,060 |
|
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
President, C.E.O. |
• • – |
2006-08-09 |
4 |
AS |
$15.01 |
$446,365 |
D/D |
(29,300) |
1,161,360 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
